Senores Pharmaceuticals Limited (NSE:SENORES)

Senores Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1,007	455.5	1,054	76.5	1	20.2
Short-Term Investments	-	1,141	2,801	52.1	-	11.95
Cash & Short-Term Investments	1,007	1,596	3,855	128.6	1	32.15
Cash Growth	-50.31%	-58.60%	2897.67%	12760.00%	-96.89%	-
Accounts Receivable	2,532	4,973	2,407	1,781	383.77	196.31
Other Receivables	-	1.7	0.6	-	-	-
Receivables	2,532	4,975	2,408	1,784	383.77	196.31
Inventory	975.6	892.9	566.3	373.7	31.24	29.83
Prepaid Expenses	-	155.2	72.1	30.3	12.02	0.14
Restricted Cash	-	-	-	2	-	-
Other Current Assets	3,149	505.1	322.8	190.5	85.34	12.09
Total Current Assets	7,663	8,124	7,224	2,509	513.37	270.52
Property, Plant & Equipment	3,910	3,627	2,524	1,791	152.64	61.16
Long-Term Investments	59.4	61.9	13.3	194.9	168.54	155.48
Goodwill	465.5	465.5	382.1	382.1	-	-
Other Intangible Assets	4,202	3,388	1,826	1,152	464.43	88.42
Long-Term Deferred Tax Assets	22.8	-	186.7	149.6	-	4.51
Other Long-Term Assets	483.1	371.4	112.4	40	10.57	1.07
Total Assets	16,806	16,038	12,269	6,219	1,311	591.52

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,511	2,347	672.2	1,130	135.82	71.36
Accrued Expenses	-	92.3	90.1	80.5	10.68	2.12
Short-Term Debt	-	331.9	312.2	323.9	81.57	19.91
Current Portion of Long-Term Debt	1,816	1,028	1,111	823.4	228.74	-
Current Portion of Leases	31.1	17.6	17.9	14.8	2.48	1.41
Current Income Taxes Payable	338.8	202.3	134.9	71.1	15.85	1.28
Other Current Liabilities	419.3	220.4	68.9	31.2	43.69	2.77
Total Current Liabilities	4,116	4,240	2,407	2,475	518.83	98.85
Long-Term Debt	2,129	1,949	1,625	1,337	297.32	122.16
Long-Term Leases	191.9	131.8	82	77.8	15.83	4.07
Pension & Post-Retirement Benefits	-	26.7	13.3	7.7	1.48	0.54
Long-Term Deferred Tax Liabilities	-	5.9	-	-	20.96	-
Other Long-Term Liabilities	54.2	39.4	19.2	4.7	1.12	-
Total Liabilities	6,491	6,393	4,146	3,902	855.54	225.62

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	460.5	460.5	460.5	305.1	98.15	87.42
Additional Paid-In Capital	-	6,765	6,551	-	-	-
Retained Earnings	-	1,887	899.1	1,758	352.91	252.49
Comprehensive Income & Other	9,569	224.3	-48.3	-20.5	3.93	25.99
Total Common Equity	10,030	9,336	7,862	2,043	454.99	365.9
Minority Interest	285.5	309.4	260.6	274.4	-	-
Shareholders' Equity	10,315	9,645	8,123	2,317	454.99	365.9
Total Liabilities & Equity	16,806	16,038	12,269	6,219	1,311	591.52

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	4,168	3,459	3,148	2,576	625.94	147.55
Net Cash (Debt)	-3,161	-1,862	707.5	-2,448	-624.94	-115.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-69.08	-40.44	19.45	-94.99	-49.27	-21.05
Filing Date Shares Outstanding	44.62	46.05	46.05	33.27	9.82	9.82
Total Common Shares Outstanding	44.62	46.05	46.05	30.5	9.82	9.82
Working Capital	3,547	3,884	4,817	34.1	-5.46	171.67
Book Value Per Share	224.78	202.72	170.71	66.96	46.36	37.28
Tangible Book Value	5,362	5,483	5,654	508.6	-9.44	277.48
Tangible Book Value Per Share	120.17	119.05	122.77	16.67	-0.96	28.27
Land	-	717.6	499.4	499.3	53.01	53.02
Buildings	-	1,282	791.3	497.8	-	-
Machinery	-	1,766	885.6	589.4	2.93	0.45
Construction In Progress	-	174.6	441.7	177.7	80.55	3.46

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error